Summary of COVID-19 Regulatory Updates Between July 15 -21 Can't see this email? View online.

July 22, 2020

Welcome to the Verisys Weekly Newsletter highlighting the COVID-19 regulatory updates between July 15 - 21, 2020.  

Verisys' Compliance Team gathers information from a variety of state and federal sources and updates our COVID-19 Resource Page daily with those updates. We have compiled the most recent updates from the past week in this email to assist your organization in serving patients during the pandemic and maintaining compliance as you bring additional providers on board to serve on the frontlines.

 

STATE BOARD REGULATIONS
 
Board of Pharmacy  
 
California  
07/17/2020: The following waivers have been extended:  
 
- Remote Processing: Effective through September 22, 2020  
- Requirements for Consulting Pharmacist to Make Quarterly Visits: Effective through September 22, 2020  
- USP <797> Requirements Related to Use of PPE: Effective through September 22, 2020  
Source: Pharmacy Law Waivers  
 
 
Board of Medicine  
 
Colorado  
07/15/2020: Amending and Extending Executive Orders D 2020 071 and D 2020 107 Concerning the Suspension of Statutes to Allow the Operation of Alternate Care Sites in Colorado Due to the Presence of COVID-19.  
Source: Executive Order 2020-137  
 
Florida  
07/15/2020: Florida Agency for Health Care Administration has released hospital screening requirements for long-term care facility residents.  
Source: Emergency Rule  
Emergency Rule Clarification  
 
 
Board of Nursing  
 
South Carolina  
07/17/2020:  
An unlicensed graduate of an accredited basic nursing education program, who applies for initial licensure by examination may be temporarily authorized to practice as a Graduate Nurse-Registered Nurse (GN-RN or Graduate Nurse-Practical Nurse (GN-PN), pending the taking of NCLEX (subject to stipulations). This temporary authorization to practice remains in effect for the duration of the declared public health state of emergency.  
Source: Graduate Nurse temporary licensure  
 
 
Disclaimer:  
This information has been gathered from a variety of sources. Although Verisys has made every effort to provide complete, accurate and up-to-date information, Verisys makes no warranties, express or implied, or representations as to the accuracy or reliability of this information. The information is fluid and evolving. Verisys assumes no liability or responsibility for any errors or omissions in the information contained in this resource.  
 
The information contained in this newsletter comprises all the information that we have found during those dates. It may not constitute a complete list of every regulation instituted by every board during the last week.

Stay well,  
The Verisys Team  
1-888-VERISYS (837-4797)
customerservice@verisys.com

DISCLAIMER: YOU UNDERSTAND AND AGREE THAT IF YOU DOWNLOAD OR OTHERWISE OBTAIN MATERIALS, INFORMATION, PRODUCTS, SOFTWARE, PROGRAMS, OR SERVICES, YOU DO SO AT YOUR OWN DISCRETION AND RISK AND THAT YOU WILL BE SOLELY RESPONSIBLE FOR ANY DAMAGES THAT MAY RESULT, INCLUDING LOSS OF DATA OR DAMAGE TO YOUR COMPUTER SYSTEM.
                   
About Us | Privacy Policy | info@verisys.com
©2020 Verisys, All Rights Reserved |
Verisys Corporation
1001 N. Fairfax Street
Suite 640
Alexandria, VA 22314

Update email preferences